Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novo Nordisk
Novo Nordisk
Why the obesity drug market is about to get a lot more crowded
Medical Marketing and Media
Fri, 04/26/24 - 11:49 am
obesity
Novo Nordisk
Wegovy
Eli Lilly
Zepbound
Roche
AstraZeneca
US Senate committee investigates pricing of Novo's Ozempic and Wegovy
Reuters
Wed, 04/24/24 - 09:16 pm
Senate
Bernie Sanders
drug pricing
Novo Nordisk
Ozempic
Wegovy
About 3.6 mln Medicare beneficiaries could be eligible for Wegovy coverage, study shows
Reuters
Wed, 04/24/24 - 09:59 am
Novo Nordisk
Wegovy
weight loss
Medicare
Big Pharma market caps surge to start 2024 despite economic headwinds
Medical Marketing and Media
Tue, 04/23/24 - 10:38 am
Big Pharma
market cap
Novo Nordisk
Eli Lilly
Ozempic's latest reported side effect: pregnancy
Axios
Fri, 04/19/24 - 11:23 am
Novo Nordisk
Ozempic
Wegovey
diabetes
PCOS
Fertility
Drugs Like Ozempic And Mounjaro Could Treat Other Conditions—Here’s What Scientists Are Looking At
Forbes
Thu, 04/18/24 - 10:25 pm
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Zepbound
Mounjaro
anxiety
addiction
heart disease
liver disease
Lawmakers probe Novo Nordisk over drug's discontinuation
Beckers Hospital Review
Wed, 04/17/24 - 10:01 pm
Novo Nordisk
Levemir
Senate
insulin
diabetes
3 patent expirations in 2024 and how companies are pivoting
Pharma Voice
Wed, 04/17/24 - 11:13 am
patents
patent cliff
Bayer
J&J
Xarelto
Novo Nordisk
Victoza
Otsuka
Lundbeck
Abilify
4 Investigational Weight Loss Drugs That Could Change the Market
BioSpace
Mon, 04/15/24 - 11:09 am
weight loss
Novo Nordisk
CagriSema
Eli Lilly
orforglipro
Viking Therapeutics
VK-2735
Inversago Pharma
INV-202
European regulators find no evidence of link between new obesity medicines and suicidal thoughts
Stat
Fri, 04/12/24 - 11:09 am
Novo Nordisk
Ozempic
Wegovy
EMA
obesity
weight loss
suicide
GLP-1s Like Novo Nordisk’s Ozempic Do Not Increase Thyroid Cancer Risk: Study
BioSpace
Wed, 04/10/24 - 09:48 am
Novo Nordisk
Ozempic
Victoza
GLP-1 agonist
thyroid cancer
EMA to Review Diabetes and Weight-Loss Drugs for Suicidal Ideation Risk
BioSpace
Tue, 04/9/24 - 11:11 am
EMA
Europe
diabetes
weight loss
Novo Nordisk
Ozempic
Wegovy
Eli Lilly
Trulicity
Saxenda
Rybelsus
Victoza
Brand managers reflect on historic launch of Wegovy
Medical Marketing and Media
Mon, 04/8/24 - 12:01 pm
Novo Nordisk
Wegovy
obesity
drug launches
brand management
FTC Will Have More Time to Review Novo’s $16.5B Catalent Buy
BioSpace
Fri, 04/5/24 - 11:52 am
Novo Nordisk
M&A
Catalent
SEC
Novo Nordisk pushes back after price gouging accusations by Bernie Sanders
Biopharma Reporter
Thu, 04/4/24 - 10:55 am
Novo Nordisk
Wegovy
Ozempic
Bernie Sanders
drug pricing
Drugmaker seeks approval for China's first biosimilar Ozempic
Reuters
Wed, 04/3/24 - 11:07 am
Novo Nordisk
Ozempic
China
biosimilars
Hangzhou Jiuyuan Gene Engineering
Medicare Will Now Cover Weight-Loss Drug Wegovy
Forbes
Mon, 04/1/24 - 11:20 pm
Wegovy
Novo Nordisk
Medicare
Medicaid
Sanders Blasts Novo Nordisk for ‘Outrageous’ Price of Ozempic, Wegovy
BioSpace
Thu, 03/28/24 - 11:22 am
Novo Nordisk
Bernie Sanders
Ozempic
Wegovy
drug pricing
obesity
diabetes
Ozempic-like drugs linked to low, but increased risk of post-endoscopy pneumonia, study finds
Stat
Thu, 03/28/24 - 11:19 am
Ozempic
obesity
diabetes
Novo Nordisk
aspiration pneumonia
Eli Lilly
Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer
Marketbeat
Tue, 03/26/24 - 11:32 am
Novo Nordisk
NVIDIA
artificial intelligence
supercomputer
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »